Search Results for: macular degeneration

How risky are stem cell trials for Parkinson’s beginning in China?

/ / 16 Comments
Brain-PET-scan, stem cells

New human clinical trials using derivatives of pluripotent stem cells in China for Parkinson’s Disease (PD) have raised expectations and some eyebrows. PD is a neurodegenerative condition, sometimes diagnosed or followed by PET scans such as the one at left, characterized by loss of dopaminergic neurons leading to severe and sometimes life-threatening symptoms. Pluripotent stem […]

How risky are stem cell trials for Parkinson’s beginning in China? Read More »

Brief update from Bob Lanza on Astellas stem cell program

/ / 25 Comments
Lanza-Astellas

Late in 2015, one of the pioneering stem cell and regenerative medicine biotechs, Ocata Therapeutics (fka as ACT or Advanced Cell Technology) was acquired by Astellas Pharma. At the time of purchase, Ocata had a number of areas of focus, but was most closely followed for its development of human embryonic stem cell-based retinal pigmented epithelial

Brief update from Bob Lanza on Astellas stem cell program Read More »

Takahashi team IPS cell vision paper marks major stem cell milestone

/ / 3 Comments
Takahashi-IPS-transplant

Ring the bell for a stem cell milestone, specifically for iPS cell work. There’s been a whole lot of commotion about the NEJM article yesterday documenting the experiences of three women with macular degeneration who were blinded by non-FDA approved stem cell eye injections of fat stem cells at a business in Florida, but in the

Takahashi team IPS cell vision paper marks major stem cell milestone Read More »

Samantha Yammine: Multiple filters for stem cell research at Canadian stem cell conference

/
stem-cell-pictures

By Samantha Yammine, PhD Candidate in Derek van der Kooy’s lab at the University of Toronto. See tweets live from #TMM2016 via @SamanthaZY here. Last week, 430 Canadian scientists, trainees, industry professionals, science communicators and international guests gathered in the picturesque ski town of Whistler, British Columbia for the annual Till & McCulloch meeting (TMM).

Samantha Yammine: Multiple filters for stem cell research at Canadian stem cell conference Read More »

Cynata approval for 1st ever allo trial of IPSC-derived MSCs for GVHD

/ / 6 Comments
Cynata

Cynata Therapeutics Limited has received approval from UK regulators to start a first-of-its-kind allogeneic IPSC-based trial of MSCs for graft versus host disease (GVHD). Cynata also had some big news a couple weeks back with a deal with Fujifilm. The company is aiming to recruit 16 patients to test whether the MSCs (a type of adult

Cynata approval for 1st ever allo trial of IPSC-derived MSCs for GVHD Read More »

Negative stem cell clinic outcomes include 3 blinded women

/ / 6 Comments
Michael-Miller-MD-PhD-e1473364751156

What can go wrong with unapproved stem cell clinic offerings? The answer including from presentations at the FDA today turns out to be very serious, negative results right here in the U.S. Thomas Albini, MD gave a talk entitled,  “Severe Visual Loss After Intravitreal Injection of Autologous Adipose Tissue-derived Stem Cells for Age-related Macular Degeneration”.

Negative stem cell clinic outcomes include 3 blinded women Read More »